AUT00201

DRUG2 trials

Sponsors

Autifony Therapeutics Limited

Conditions

Healthy VolunteerMyoclonus Epilepsies, Progressive

Phase 1

Safety, Blood Levels and Effects of AUT00201

CompletedNCT04158453

Autifony Therapeutics LimitedHealthy Volunteer

Start: 2019-10-10End: 2020-12-24Updated: 2021-01-13

Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK

CompletedNCT05873062

Autifony Therapeutics LimitedMyoclonus Epilepsies, Progressive

Start: 2023-05-12End: 2024-05-01Updated: 2025-03-25